131 related articles for article (PubMed ID: 32841447)
1. ERO1L promotes NSCLC development by modulating cell cycle-related molecules.
Shi X; Wu J; Liu Y; Jiang Y; Zhi C; Li J
Cell Biol Int; 2020 Dec; 44(12):2473-2484. PubMed ID: 32841447
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer.
Zhang J; Yang J; Lin C; Liu W; Huo Y; Yang M; Jiang SH; Sun Y; Hua R
Theranostics; 2020; 10(18):8400-8414. PubMed ID: 32724477
[No Abstract] [Full Text] [Related]
3. ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway.
Han F; Xu Q; Zhao J; Xiong P; Liu J
J Cell Biochem; 2018 Nov; 119(11):8996-9005. PubMed ID: 30076651
[TBL] [Abstract][Full Text] [Related]
4. ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer.
Yang J; Xu Y; Huo Y; Cai L; Hua R; Zhang J; Chen Z
J Immunol Res; 2021; 2021():5553425. PubMed ID: 33681386
[TBL] [Abstract][Full Text] [Related]
5. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Endoplasmic Reticulum Oxidoreductin 1-α (ERO1L) Is Associated with Poor Prognosis of Gastric Cancer.
Seol SY; Kim C; Lim JY; Yoon SO; Hong SW; Kim JW; Choi SH; Cho JY
Cancer Res Treat; 2016 Oct; 48(4):1196-1209. PubMed ID: 26987398
[TBL] [Abstract][Full Text] [Related]
7. ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β-catenin signaling pathway.
Xie J; Liao G; Feng Z; Liu B; Li X; Qiu M
Mol Carcinog; 2022 Oct; 61(10):897-909. PubMed ID: 35785492
[TBL] [Abstract][Full Text] [Related]
8. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
9. TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer.
Zhou F; Wang M; Aibaidula M; Zhang Z; Aihemaiti A; Aili R; Chen H; Dong S; Wei W; Maimaitiaili A
Med Sci Monit; 2020 Aug; 26():e925147. PubMed ID: 32748897
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
[TBL] [Abstract][Full Text] [Related]
11. STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer.
Ma Z; Liu D; Li W; Di S; Zhang Z; Zhang J; Xu L; Guo K; Zhu Y; Han J; Li X; Yan X
Cell Death Dis; 2019 Jun; 10(6):435. PubMed ID: 31164631
[TBL] [Abstract][Full Text] [Related]
12. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
Feng H; Ge F; Du L; Zhang Z; Liu D
J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
[TBL] [Abstract][Full Text] [Related]
13. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
Xiang J; Hang JB; Che JM; Li HC
Int J Clin Exp Pathol; 2015; 8(8):9147-53. PubMed ID: 26464659
[TBL] [Abstract][Full Text] [Related]
14. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
Yang W; Zhou C; Luo M; Shi X; Li Y; Sun Z; Zhou F; Chen Z; He J
Oncotarget; 2016 Mar; 7(13):16703-15. PubMed ID: 26934648
[TBL] [Abstract][Full Text] [Related]
15.
Liu L; Wang C; Li S; Qu Y; Xue P; Ma Z; Zhang X; Bai H; Wang J
Front Immunol; 2021; 12():677169. PubMed ID: 34354701
[TBL] [Abstract][Full Text] [Related]
16. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
[TBL] [Abstract][Full Text] [Related]
18. Epithelial Membrane Protein 2 Suppresses Non-Small Cell Lung Cancer Cell Growth by Inhibition of MAPK Pathway.
Ma Y; Schröder DC; Nenkov M; Rizwan MN; Abubrig M; Sonnemann J; Murrieta-Coxca JM; Morales-Prieto DM; Westermann M; Gaßler N; Chen Y
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799364
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma.
Hsu CH; Hsu CW; Hsueh C; Wang CL; Wu YC; Wu CC; Liu CC; Yu JS; Chang YS; Yu CJ
Mol Cell Proteomics; 2016 Jul; 15(7):2396-410. PubMed ID: 27161446
[TBL] [Abstract][Full Text] [Related]
20. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
